Distinguishing community-associated from hospital-associated Clostridium difficile infections in children: implications for public health surveillance.

BACKGROUND Children are increasingly recognized as being at risk for C. difficile infection (CDI), even without prior exposure to antibiotics or the healthcare environment. We aimed to distinguish risk factors, clinical course, and outcomes between healthcare facility-associated (HA) and community-associated (CA) CDI. METHODS This was a retrospective, observational cohort study conducted at the Johns Hopkins Children's Center, Baltimore, Maryland. All inpatients, aged ≥1 year, hospitalized from July 2003 to July 2012 and diagnosed with CDI based on clinical characteristics and confirmatory laboratory testing were included. The main outcome was CDI, categorized as HA-CDI, CA-CDI, and "indeterminate" (classified as disease onset in the community, 4-12 weeks from hospital discharge). RESULTS Two hundred two pediatric inpatients were diagnosed with CDI, of whom 38 had CA-CDI, 144 had HA-CDI, and 20 had indeterminate CDI. Children with indeterminate CDI had baseline characteristics similar to those identified for HA-CDI. Children hospitalized with CA-CDI were less likely to have comorbidities (odds ratio [OR], 0.14; 95% confidence interval [CI], .03-.65; P = .013), to have been exposed to antibiotics (OR, 0.17; 95% CI, .07-.44; P < .001), or prior surgeries (OR, 0.03; 95% CI, .00-.24; P = .001), compared to children with HA-CDI. Compared with HA-CDI, children with CA-CDI had a trend toward more episodes of septic shock (P = .07), toxic megacolon (P = .04), and recurrences (P = .04). CONCLUSIONS In a hospitalized cohort, CA-CDI is more often seen in previously healthy children without antibiotic exposure or comorbid conditions and has more frequent complications and recurrences compared to HA-CDI. For surveillance purposes, "indeterminate" CDI should be allocated to HA-CDI rather than CA-CDI.

[1]  S. Coffin,et al.  Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  G. Schutze,et al.  Clostridium difficile Infection in Infants and Children , 2013, Pediatrics.

[3]  P. Tamma,et al.  Clostridium difficile Infection in Children: Current State and Unanswered Questions. , 2012, Journal of the Pediatric Infectious Diseases Society.

[4]  T. Perl,et al.  Clostridium difficile: novel insights on an incessantly challenging disease , 2012, Current opinion in infectious diseases.

[5]  D. Cardo,et al.  The power of policy change, federal collaboration, and state coordination in healthcare-associated infection prevention. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  D. Saltzman,et al.  Clostridium difficile infection in the pediatric surgery population. , 2012, Journal of pediatric surgery.

[7]  B. Hota,et al.  A Multicenter Study of Clostridium difficile Infection—Related Colectomy, 2000—2006 , 2012, Infection Control &#x0026; Hospital Epidemiology.

[8]  Anil K. Jain,et al.  Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  A. Sarah Walker,et al.  Characterisation of Clostridium difficile Hospital Ward–Based Transmission Using Extensive Epidemiological Data and Molecular Typing , 2012, PLoS medicine.

[10]  Daniel J. Shapiro,et al.  Antibiotic Prescribing in Ambulatory Pediatrics in the United States , 2011, Pediatrics.

[11]  I. Brukner,et al.  Host and pathogen factors for Clostridium difficile infection and colonization. , 2011, The New England journal of medicine.

[12]  Gerry Fairbrother,et al.  Clostridium difficile infection in hospitalized children in the United States. , 2011, Archives of pediatrics & adolescent medicine.

[13]  S. Vindigni,et al.  Clostridium difficile Infections among Hospitalized Children, United States, 1997–2006 , 2010, Emerging infectious diseases.

[14]  L. McDonald,et al.  Clostridium difficile Infections among Hospitalized Children, United States, 1997–2006 , 2010, Emerging infectious diseases.

[15]  D. Gerding,et al.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) , 2010, Infection Control &#x0026; Hospital Epidemiology.

[16]  L. Greco,et al.  Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection , 2009, Alimentary pharmacology & therapeutics.

[17]  E. Kuijper,et al.  Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[18]  T. Zaoutis,et al.  Presence of the epidemic North American Pulsed Field type 1 Clostridium difficile strain in hospitalized children. , 2009, The Journal of pediatrics.

[19]  S. Coffin,et al.  Epidemiological Features of Clostridium difficile-Associated Disease Among Inpatients at Children's Hospitals in the United States, 2001–2006 , 2008, Pediatrics.

[20]  J. Corver,et al.  Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  Surveillance for community-associated Clostridium difficile--Connecticut, 2006. , 2008, MMWR. Morbidity and mortality weekly report.

[22]  Joseph M. Campos,et al.  Changing Epidemiology of Clostridium difficile-Associated Disease in Children , 2007, Infection Control &#x0026; Hospital Epidemiology.

[23]  D. Gerding,et al.  Onset of Symptoms and Time to Diagnosis of Clostridium difficile–Associated Disease Following Discharge From an Acute Care Hospital , 2007, Infection Control &#x0026; Hospital Epidemiology.

[24]  T. Horan,et al.  Recommendations for Surveillance of Clostridium difficile–Associated Disease , 2007, Infection Control &#x0026; Hospital Epidemiology.

[25]  K. Sepkowitz,et al.  Risk Factors for Acquisition of Clostridium difficile–Associated Diarrhea among Outpatients at a Cancer Hospital , 2005, Infection Control &#x0026; Hospital Epidemiology.

[26]  T. Karasawa,et al.  Colonization by Clostridium difficile of neonates in a hospital, and infants and children in three day-care facilities of Kanazawa, Japan. , 2005, International microbiology : the official journal of the Spanish Society for Microbiology.

[27]  J. Gerberding,et al.  Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005. , 2005, MMWR. Morbidity and mortality weekly report.

[28]  T. Åkerlund,et al.  Molecular Epidemiology of Hospital-Associated and Community-Acquired Clostridium difficile Infection in a Swedish County , 2004, Journal of Clinical Microbiology.

[29]  W. Stamm,et al.  Nosocomial acquisition of Clostridium difficile infection. , 1989, The New England journal of medicine.